NCT06646406View on ClinicalTrials.gov

Evaluation of a Multilevel Intervention on Adult COVID-19 and Influenza Vaccination Rate

NACompletedINTERVENTIONAL
Enrollment

114,165

Participants

Timeline

Start Date

October 21, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
COVID-19 ImmunisationInfluenza Vaccine
Interventions
BEHAVIORAL

Patient letter and clinician communication

Single mailing to patients from practice with a reminder that the influenza and COVID-19 vaccines are due, and monthly emailing to the patients' clinicians with information about how to make a strong recommendation for those vaccines

Trial Locations (2)

55902

Mayo Clinic, Rochester

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

ModernaTX, Inc.

INDUSTRY

lead

Mayo Clinic

OTHER

NCT06646406 - Evaluation of a Multilevel Intervention on Adult COVID-19 and Influenza Vaccination Rate | Biotech Hunter | Biotech Hunter